Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology
Disease Category: Depression (Treatment-Resistant)
Trial Information
Treatment of Resistant Depression in Adolescents
Is your teen taking Prozac ®, Zoloft ®, Celexa ® or Lexapro ®
for depression?
Is your teen still:
- Tired?
- Withdrawn?
- Feeling Down?
- Unmotivated?
- Irritable?
- Feeling worthless?
If you answered yes to any of these questions, your teen may not
be responding to his or her prescribed antidepressant medication
and may qualify to participate in a national study for the
treatment of resistant depression in adolescents (TORDIA),
sponsored by the National Institute of Mental Health.
This is a 26 week study of the effectiveness of certain
antidepressant medications for the treatment of resistant
depression and may include 12 weekly sessions of cognitive behavior
therapy. Offices are located in Clear Lake and Galveston.
Study Criteria:
- 12-18 years
- Currently (or within the last month) being treated for
depression with an SSRI (Prozac, Celexa, Lexapro or Zoloft) that
doesn't appear to be working.
For more information,
Stacy D. Smith, MSW, Recruitment Coordinator
University of Texas Medical Branch, Office of Clinical Trials
301 University
1110 Nasa Parkway, Suite 400
Galveston/Houston, TX
Phone: 800-236-2898
Fax: 281-335-5335
EMail: stsmith@utmb.edu
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
